\documentclass{bmcart}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%                                          %%
%% CARGA DE PAQUETES DE LATEX               %%
%%                                          %%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

%%% Load packages
\usepackage{amsthm,amsmath}
\usepackage{graphicx}
%\RequirePackage[numbers]{natbib}
%\RequirePackage{hyperref}
\usepackage[utf8]{inputenc} %unicode support
%\usepackage[applemac]{inputenc} %applemac support if unicode package fails
%\usepackage[latin1]{inputenc} %UNIX support if unicode package fails


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%                                          %%
%% COMIENZO DEL DOCUMENTO                   %%
%%                                          %%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\begin{document}

	\begin{frontmatter}
	
		\begin{fmbox}
			\dochead{Research}
			
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			%% INTRODUCIR TITULO PROYECTO               %%
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			
			\title{Reposicionamiento de fármacos en COVID-19}
			
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			%% AUTORES. METER UNA ENTRADA AUTHOR        %%
			%% POR PERSONA                              %%
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			
			\author[
			  addressref={aff1},                   % ESTA LINEA SE COPIA IGUAL PARA CADA AUTOR
			  corref={aff1},                       % ESTA LINEA SOLO DEBE TENERLA EL COORDINADOR DEL GRUPO
			  email={lauranunezj99@uma.es}   % VUESTRO CORREO ACTIVO
			]{\inits{L.N.J}\fnm{Laura} \snm{Núñez Jiménez}} % inits: INICIALES DE AUTOR, fnm: NOMBRE DE AUTOR, snm: APELLIDOS DE AUTOR
			\author[
			  addressref={aff1},
			  email={john.RS.Smith@cambridge.co.uk}
			]{\inits{I.J.P}\fnm{Inmaculada} \snm{Jiménez Palomino}}
			\author[
			  addressref={aff1},
			  email={talal.awija@gmail.com}
			]{\inits{T.A}\fnm{Talal} \snm{Awija}}
			
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			%% AFILIACION. NO TOCAR                     %%
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			
			\address[id=aff1]{%                           % unique id
			  \orgdiv{ETSI Informática},             % department, if any
			  \orgname{Universidad de Málaga},          % university, etc
			  \city{Málaga},                              % city
			  \cny{España}                                    % country
			}
		
		\end{fmbox}% comment this for two column layout
		
		\begin{abstractbox}
		
			\begin{abstract} % abstract
			
            A continuación, el informe trata sobre los fármacos que tienen efecto sobre las proteínas humanas que interaccionan con las 27 proteínas del Covid-19. Este caso surge debido a la pandemia vivida en nuestros días producida por el virus SARS-CoV-2, el cual está causando millones de contagios alrededor del mundo y miles de muertes. Una de las principales causas por lo que no se desarrolla de manera efectiva la creación de fármacos es por el poco conocimiento que se tiene sobre el virus. Por ello, se requiere de la búsqueda de fármacos ya existentes que puedan interaccionar con las conexiones entre proteína humana y el SARS-CoV-2, y así afectar a la reacción del virus. Nos basamos en implementar la reutilización de medicamentos basadas en la red que surge de esta relación, lo que permite clasificar todos los medicamentos aprobados en función de su posible eficacia. Usando las bases de datos STRING obtendremos dicha red, que nos ayudará a obtener las 332 proteínas humanas, las cuales, usaremos posteriormente en la base de datos de ChEMBL. Con dicha base de datos obtendremos en él, el experimento de fármacos potenciales, así como información sobre cada uno de ellos. 

 
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			%% RESUMEN BREVE DE NO MAS DE 100 PALABRAS   %%
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%	
			
			\end{abstract}
			
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			%% PALABRAS CLAVE DEL PROYECTO              %%
			%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
			
			\begin{keyword}
			\kwd{Covid-19}
			\kwd{SARS-CoV-2}
			\kwd{ChEMBL}
			\kwd{Fármacos experimentales}
			\end{keyword}
		
		
		\end{abstractbox}
	
	\end{frontmatter}

	%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
	%% COMIENZO DEL DOCUMENTO REAL %%
	%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
	
	\input{tex_files/introduction.tex}
	\input{tex_files/material_methods.tex}
	\input{tex_files/resultados.tex}
	\input{tex_files/discusion.tex}
	\input{tex_files/conclusiones.tex}
	
	
	%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
	%% OTRA INFORMACIÓN                         %%
	%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
	
	\begin{backmatter}
		
		\section*{Disponibilidad de datos y materiales}%% if any
			https://github.com/talal314/project_template.git
		
		\section*{Contribución de los autores}
			T.A:Uso y descarga de la base de datos ChEMBL,consultas y recorrido de tablas sobre la bases de datos, Connectar a la base de datos desde python para guardar los resultados en una tabla y filtración de datos con R. 
			
			I.J.P: Obtención de las proteinas humanas, creación de igraph y mapeo de dichas proteínas, filtración de las interacciones con combined score y transformación del id a uniprot id. 
			
			L.N.J: Redacción del informe de la investigación. Consultar y buscar información en artículos y la obtención de las 29 proteínas del SARS-CoV-2. 
		
		
		%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
		%% BIBLIOGRAFIA: no teneis que tocar nada, solo sustituir el archivo bibliography.bib %%
		%% por el que hayais generado vosotros                                                %%
		%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
		
		\bibliographystyle{bmc-mathphys} % Style BST file (bmc-mathphys, vancouver, spbasic).
		\bibliography{library}      % Bibliography file (usually '*.bib' )
	
	\end{backmatter}
\end{document}
